Insider Selling: David P. King Sells 65,233 Shares of Laboratory Corp. of America Holdings Stock (LH)
Laboratory Corp. of America Holdings (NYSE:LH) CEO David P. King sold 65,233 shares of the company’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $106.10, for a total value of $6,921,221.30. Following the sale, the chief executive officer now directly owns 55,583 shares in the company, valued at approximately $5,897,356. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Laboratory Corp. of America Holdings in a research note on Thursday, July 24th. They now have a $111.00 price target on the stock. Separately, analysts at William Blair upgraded shares of Laboratory Corp. of America Holdings from a “market perform” rating to an “outperform” rating in a research note on Thursday, July 17th. Finally, analysts at Maxim Group raised their price target on shares of Laboratory Corp. of America Holdings from $110.00 to $120.00 in a research note on Thursday, July 17th. They now have a “buy” rating on the stock. Nine investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $105.15.
Laboratory Corp. of America Holdings (NYSE:LH) traded down 0.47% on Tuesday, hitting $106.43. 357,425 shares of the company’s stock traded hands. Laboratory Corp. of America Holdings has a 52 week low of $87.01 and a 52 week high of $108.00. The stock has a 50-day moving average of $104.7 and a 200-day moving average of $100.2. The company has a market cap of $9.036 billion and a price-to-earnings ratio of 17.79.
Laboratory Corp. of America Holdings (NYSE:LH) last issued its quarterly earnings data on Friday, July 18th. The company reported $1.84 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.77 by $0.07. The company had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the prior year, the company posted $1.80 earnings per share. The company’s quarterly revenue was up 3.3% on a year-over-year basis. On average, analysts predict that Laboratory Corp. of America Holdings will post $6.72 earnings per share for the current fiscal year.
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.
Receive News & Ratings for Laboratory Corp of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp of America Holdings and related companies with Analyst Ratings Network's FREE daily email newsletter.